Results 191 to 200 of about 68,021 (347)

Engineering metal‐organic framework‐based smart porous nanoplatforms for targeted therapy and theranostic applications

open access: yesSmart Molecules, EarlyView.
MOFs offer high porosity and tunability for biomedical applications, especially in cancer therapy via ROS generation and targeted delivery. Though toxicity, stability, and scalability remain key clinical challenges. Drug loading in MOFs exceeds 60%–70% with controlled release behavior.
Jagabandhu Bag   +6 more
wiley   +1 more source

Home Phototherapy for Psoriasis: Evidence and Implementation. [PDF]

open access: yesPhotodermatol Photoimmunol Photomed
Ghanim D   +7 more
europepmc   +1 more source

Engineering ApoE‐Mimetic HDL‐Like Nanoparticles for Glioblastoma‐Targeted Theranostics

open access: yesSmall Methods, EarlyView.
An ApoE‐mimetic peptide enables the stable formation of sub‐30 nm HDL‐like nanoparticles (ApoEm‐PLP) that simultaneously engage multiple lipoprotein receptors. This multivalent receptor interaction facilitates the transport of ApoEm‐PLP into brain and enhances targeted delivery of ApoEm‐PLP to glioblastoma, resulting in uniform intratumoral porphyrin ...
Hanyi Weng   +12 more
wiley   +1 more source

Bilirubin kinetics in preterm infants. [PDF]

open access: yesJ Perinatol
Hegyi T, Cordero N, Halari A, Petrova A.
europepmc   +1 more source

Treatment Patterns and Pathways of Systemic Drug Therapy in Patients With Plaque, Erythrodermic, and Generalized Pustular Psoriasis: A Retrospective Cohort Study in Japan

open access: yesThe Journal of Dermatology, EarlyView.
ABSTRACT Systemic psoriasis treatment options have rapidly expanded in Japan, including the approval of tyrosine kinase 2 and interleukin‐36 receptor inhibitors in 2022. However, contemporary real‐world treatment patterns across plaque, erythrodermic, and generalized pustular psoriasis remain incompletely characterized.
Yayoi Tada   +9 more
wiley   +1 more source

Effectiveness and Safety of Vunakizumab Over 12 Weeks in Chinese Patients With Plaque Psoriasis: A Prospective, Real‐World Cohort Study

open access: yesThe Journal of Dermatology, EarlyView.
ABSTRACT Vunakizumab is a humanized anti‐IL‐17A monoclonal antibody approved in China for moderate‐to‐severe plaque psoriasis. Real‐world data on its effectiveness and predictors of response remain scarce. This prospective, single‐center, observational study enrolled 34 adults receiving vunakizumab (240 mg subcutaneously at weeks 0, 2, and 4, then ...
Tong Wu   +4 more
wiley   +1 more source

Narrow-band UV-B (TL-01) Phototherapy Exposure and Skin Cancer Risk: A Nested Case-control Study. [PDF]

open access: yesActa Derm Venereol
Åkerla P   +4 more
europepmc   +1 more source

Added Value of Estimated Fetal Weight Growth Velocity to Doppler Evaluation for the Prediction of Perinatal Outcomes Among Foetuses With EFW < 10th Centile at Term: A Retrospective Cohort Study

open access: yesBJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Objective To evaluate whether estimated fetal weight (EFW) growth velocity (GV), assessed using interval‐specific standards, provides additional prediction beyond standard criteria for identifying adverse outcomes in term foetuses with EFW < 10th centile. Design Retrospective cohort study. Setting Tertiary perinatal centre. Population A cohort
Eva Meler   +6 more
wiley   +1 more source

A New Phototherapy Regimen Coupled with Oral Vitamin D Supplementation, for the Long-Term Control of Atopic Dermatitis: A French Multicenter, Randomized, Crossover, Pragmatic Trial. [PDF]

open access: yesDermatol Ther (Heidelb)
Droitcourt C   +16 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy